Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial.
Westhovens R, Rigby WFC, van der Heijde D, Ching DWT, Stohl W, Kay J, Chopra A, Bartok B, Matzkies F, Yin Z, Guo Y, Tasset C, Sundy JS, Jahreis A, Mozaffarian N, Messina OD, Landewé RB, Atsumi T, Burmester GR. Westhovens R, et al. Among authors: yin z. Ann Rheum Dis. 2021 Jun;80(6):727-738. doi: 10.1136/annrheumdis-2020-219213. Epub 2021 Jan 15. Ann Rheum Dis. 2021. PMID: 33452004 Free PMC article. Clinical Trial.
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3.
Aletaha D, Westhovens R, Gaujoux-Viala C, Adami G, Matsumoto A, Bird P, Messina OD, Buch MH, Bartok B, Yin Z, Guo Y, Hendrikx T, Burmester GR. Aletaha D, et al. Among authors: yin z. RMD Open. 2021 Aug;7(2):e001621. doi: 10.1136/rmdopen-2021-001621. RMD Open. 2021. PMID: 34385364 Free PMC article. Clinical Trial.
Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3).
Atsumi T, Tanaka Y, Matsubara T, Amano K, Ishiguro N, Sugiyama E, Yamaoka K, Westhovens R, Ching DWT, Messina OD, Burmester GR, Bartok B, Pechonkina A, Kondo A, Yin Z, Guo Y, Tasset C, Sundy JS, Takeuchi T. Atsumi T, et al. Among authors: yin z. Mod Rheumatol. 2022 Feb 28;32(2):273-283. doi: 10.1093/mr/roab021. Mod Rheumatol. 2022. PMID: 34910203 Clinical Trial.
Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3).
Atsumi T, Tanaka Y, Matsubara T, Amano K, Ishiguro N, Sugiyama E, Yamaoka K, Westhovens R, Ching DWT, Messina OD, Burmester GR, Genovese M, Bartok B, Pechonkina A, Kondo A, Yin Z, Gong Q, Tasset C, Takeuchi T. Atsumi T, et al. Among authors: yin z. Mod Rheumatol. 2023 Jul 4;33(4):657-667. doi: 10.1093/mr/roac083. Mod Rheumatol. 2023. PMID: 35921235 Clinical Trial.
The 2023 report of the synergetic roadmap on carbon neutrality and clean air for China: Carbon reduction, pollution mitigation, greening, and growth.
Gong J, Yin Z, Lei Y, Lu X, Zhang Q, Cai C, Chai Q, Chen H, Chen R, Chen W, Cheng J, Chi X, Dai H, Dong Z, Geng G, Hu J, Hu S, Huang C, Li T, Li W, Li X, Lin Y, Liu J, Ma J, Qin Y, Tang W, Tong D, Wang J, Wang L, Wang Q, Wang X, Wang X, Wu L, Wu R, Xiao Q, Xie Y, Xu X, Xue T, Yu H, Zhang D, Zhang L, Zhang N, Zhang S, Zhang S, Zhang X, Zhang Z, Zhao H, Zheng B, Zheng Y, Zhu T, Wang H, Wang J, He K. Gong J, et al. Among authors: yin z. Environ Sci Ecotechnol. 2024 Nov 27;23:100517. doi: 10.1016/j.ese.2024.100517. eCollection 2025 Jan. Environ Sci Ecotechnol. 2024. PMID: 39717181 Free PMC article.
8,233 results